Inhibition of adrenergic cardiopathies by drugs. II. Anticoagulants.
D000074:Acenocoumarol / Q000009:adverse effects / Q000494:pharmacology; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D006332:Cardiomegaly / Q000139:chemically induced; D003864:Depression, Chemical; D001728:Dicumarol / Q000494:pharmacology; D005017:Ethyl Biscoumacetate / Q000494:pharmacology; D005260:Female; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006470:Hemorrhage / Q000139:chemically induced; D007545:Isoproterenol / Q000037:antagonists & inhibitors*; D008297:Male; D010630:Phenindione / Q000494:pharmacology; D010653:Phenylbutazone / Q000009:adverse effects / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000494:pharmacology; D014812:Vitamin K / Q000494:pharmacology; D014859:Warfarin / Q000494:pharmacology
D000925:Anticoagulants; D005017:Ethyl Biscoumacetate; D014812:Vitamin K; D010630:Phenindione; D014859:Warfarin; D001728:Dicumarol; D012964:Sodium; D010653:Phenylbutazone; D000074:Acenocoumarol; D007545:Isoproterenol